GSK in talks with Trump administration on U.S. drug pricing, CEO says
LONDON (Reuters) -British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, becoming the latest pharmaceutical company to acknowledge action under pressure from Washington to rein in prices. GSK CEO Emma Walmsley said on a call with journalists after the company posted second-quarter profits …
GSK in talks with Trump administration on U.S. drug pricing, CEO says Read More »









